WASSERMAN MARTIN A 4
4 · ATHEROGENICS INC · Filed Nov 19, 2003
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
WASSERMAN MARTIN A
Sr VP Discovery Research
Transactions
- Sale
Common stock
2003-11-18$15.16/sh−31,000$469,960→ 0 total - Exercise/Conversion
Stock option (right to buy)
2003-11-18$6.04/sh−31,000$187,240→ 19,000 totalExercise: $6.04Exp: 2011-04-30→ Common stock (31,000 underlying) - Exercise/Conversion
Common stock
2003-11-18$6.04/sh+31,000$187,240→ 31,000 total
Footnotes (1)
- [F1]25% of these options vest on 4/30/02, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.